An Oklahoma plaintiff has brought a lawsuit against Bristol-Myers Squib Company, Sanofi-Aventis U.S. LLC., Sanofi US Services, Inc., and Sanofi-Synthelabo, Inc., claiming that the antiplatelet drug Plavix caused him to suffer multiple hemorrhaging events. The lawsuit was filed by the national law firm of Parker Waichman LLP in the Supreme Court of the State of New York, County of New York.
The lawsuit says the plaintiff used Plavix from March 2010 to November 2010, during which time he suffered two gastrointestinal hemorrhages and a cerebral hemorrhage. The plaintiff alleges that the defendants knew that Plavix increased the risk of serious hemorrhages, but that the financial success of the drug drove the manufacturers to keep it on the market, while continuing to make false and unsubstantiated claims about the safety and efficacy of Plavix.
Since Plavix hit the market in 1997, the defendants have claimed the drug was more effective at reducing the risk of blood clots, stroke and heart attack then aspirin; however, research published in the New England Journal of Medicine contradicts these claims.
The lawsuit seeks damages for severe and permanent injuries, physical pain and suffering, physical impairment, physical disfigurement, mental pain and suffering, loss of enjoyment of life, and present and future medical expenses for monitoring and treating those injuries.